Fatal e-cigarette or vaping associated lung injury (EVALI): a first case report in Europe
- 26 March 2020
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (1), 2000077
- https://doi.org/10.1183/13993003.00077-2020
Abstract
Numerous cases of e-cigarette, or vaping, associated lung injury (EVALI) have recently prompted an investigation of the outbreak in the US [1]. Only two non-fatal cases have been reported so far in Europe: one case of hypersensitivity pneumonia in the UK after the use of flavoured e-cigarette liquid by a young adolescent [2], and one US imported case recently described in Spain [3]. To our knowledge, this is the first report of a fatal EVALI case in Europe.This publication has 7 references indexed in Scilit:
- Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Final ReportThe New England Journal of Medicine, 2020
- Update: Demographic, Product, and Substance-Use Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injuries — United States, December 2019Morbidity and Mortality Weekly Report (MMWR), 2019
- An imported case of e-cigarette or vaping associated lung injury in BarcelonaEuropean Respiratory Journal, 2019
- Evaluation of Bronchoalveolar Lavage Fluid from Patients in an Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — 10 States, August–October 2019Morbidity and Mortality Weekly Report (MMWR), 2019
- Life-threatening hypersensitivity pneumonitis secondary to e-cigarettesArchives of Disease in Childhood, 2019
- Pathology of Vaping-Associated Lung InjuryThe New England Journal of Medicine, 2019
- Imaging of Vaping-Associated Lung DiseaseThe New England Journal of Medicine, 2019